A $33 million grant from the National Institute of Health to three New Jersey institutions is helping the state get one step closer to making this practice, called personalized — or translation medicine — a reality, taking medical breakthroughs from the bench to the bedside. To learn more.
Recent Posts
- DNA test says it can predict opioid addiction risk. Skeptics aren’t so sure.
- Transfer Scholars Initiative prepares N.J. community college students to thrive at selective four-year schools.
- Scientists May Have Discovered Reason for Long COVID Brain Fog—Here’s Why It Matters.
- Are You at Risk for Addiction?
- NJ health inequities are focus of Rutgers symposium.